Zenith(R) Low Profile AAA Endovascular Graft Clinical Study

March 8, 2018 updated by: Cook Group Incorporated

Evaluation of the Safety and Effectiveness of the Zenith(R) Low Profile AAA Endovascular Graft

The Zenith® Low Profile AAA Endovascular Graft Clinical Study is a clinical trial approved by US FDA to study the safety and effectiveness of the Zenith® Low Profile AAA Endovascular Graft to treat abdominal aortic, aorto-iliac, and iliac aneurysms.

Study Overview

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Expanded Access

No longer available outside the clinical trial. See expanded access record.

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hong Kong, China
        • Queen Mary Hospital
      • Munster, Germany, 48145
        • St. Franziskus Hospital
      • Moscow, Russian Federation, 111123
        • CELT Hospital
      • Malmo, Sweden
        • Malmö University Hospital
    • California
      • San Francisco, California, United States, 94143
        • University of California, San Francisco, Div. Vascular Surgery and San Francisco VAMC
      • Stanford, California, United States, 94305
        • Stanford University Medical Center
    • Connecticut
      • New Haven, Connecticut, United States, 06510
        • Yale New Haven School of Med., Dept. of Vascular Surgery
    • Florida
      • Gainesville, Florida, United States, 32610
        • University of Florida, Vascular Surgery
    • Massachusetts
      • Boston, Massachusetts, United States, 02114
        • Massachusetts General Hospital
    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • University of Michigan Hospital
      • Grand Rapids, Michigan, United States, 49546
        • Spectrum Health Butterworth
      • Royal Oak, Michigan, United States, 48073
        • William Beaumont Hospital
    • Minnesota
      • Rochester, Minnesota, United States, 55905
        • Mayo Clinic
    • Missouri
      • Saint Louis, Missouri, United States, 63141
        • Mercy Hospital
      • Saint Louis, Missouri, United States, 63141
        • Barnes-Jewish Hospital
    • New Jersey
      • Morristown, New Jersey, United States, 07960
        • Morristown Memorial Hospital
    • New York
      • New York, New York, United States, 10016
        • New York University Hospital
      • New York, New York, United States, 10032
        • New York Presbyterian Hospital - Cornell
      • Rochester, New York, United States, 14642
        • University of Rochester, Strong Memorial Hospital
    • North Carolina
      • Chapel Hill, North Carolina, United States, 27955
        • University of North Carolina
    • Ohio
      • Cleveland, Ohio, United States, 44195
        • Cleveland Clinic
      • Columbus, Ohio, United States, 43214
        • Ohio Health Research Institute
    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • Hospital of the University of Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15212
        • Allegheny General Hospital
    • Virginia
      • Falls Church, Virginia, United States, 22042
        • Fairfax INOVA Hospital
    • Washington
      • Seattle, Washington, United States, 98104
        • Harborview Medical Center
    • Wisconsin
      • Milwaukee, Wisconsin, United States, 53215
        • St. Luke's Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Abdominal aortic, aortoiliac, and iliac aneurysms of appropriate size
  • Vessels suitable for endovascular access and aneurysm repair

Exclusion Criteria:

  • Less than 18 years of age
  • Inability or refusal to give informed consent
  • Disease considerations that would compromise patient safety or study outcomes
  • Unsuitable arterial anatomy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
OTHER: 1
Treatment with Endovascular Graft
The Zenith(R) Low Profile AAA Endovascular Graft and ancillary components are indicated for the endovascular treatment of patients with abdominal aortic, aorto-iliac, or iliac aneurysms having morphology suitable for endovascular repair.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patients With Major Adverse Events (MAE)
Time Frame: 30-day
MAE is defined as any occurrence of all-cause death, Q-wave myocardial infarction (MI), renal failure requiring dialysis, paralysis, stroke, bowel ischemia, or re-intubation.
30-day
Patients With Device Failures
Time Frame: 12-month

Device success at 12-month is defined as:

Technical Success (successful access of the aneurysm site, deployment of the graft in the intended location, and patency of the graft at the time of deployment completion intra-operatively), and freedom from the following at 12 months: Type I or type III endoleaks requiring re-intervention, Aneurysm rupture or conversion to open surgical repair, and Aneurysm enlargement greater than 0.5 cm.

12-month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2008

Primary Completion (ACTUAL)

October 1, 2011

Study Completion (ACTUAL)

June 1, 2016

Study Registration Dates

First Submitted

January 30, 2009

First Submitted That Met QC Criteria

January 30, 2009

First Posted (ESTIMATE)

February 2, 2009

Study Record Updates

Last Update Posted (ACTUAL)

April 4, 2018

Last Update Submitted That Met QC Criteria

March 8, 2018

Last Verified

March 1, 2018

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Abdominal Aortic Aneurysms

Clinical Trials on Zenith(R) Low Profile AAA Endovascular Graft

3
Subscribe